Drug intelligence / Profile preview

racemethionine + choline chloride

Development stage
Unknown
Lead developer
União Química
Modality
Small Molecules
Administration
Oral
01

Overview

Xantinon is an over-the-counter hepatoprotective and lipotropic drug indicated as an aid in the treatment of liver disorders, such as non-alcoholic fatty liver disease (hepatic steatosis) and metabolic hepatic disturbances. The formulation combines racemethionine (an essential sulfur-containing amino acid) and choline chloride (a quaternary ammonium salt and precursor to phosphatidylcholine and acetylcholine). Together, these components act as lipotropic agents and methyl donors in the one-carbon transmethylation pathway. They facilitate the synthesis of lipoproteins (such as VLDL), which are essential for mobilizing and transporting triglycerides out of the liver, thereby preventing and reducing hepatic fat accumulation. Additionally, they support intracellular antioxidant defenses, helping to mitigate oxidative stress and promote the recovery of damaged hepatocytes.

Brand names
Xantinon
Other names
DL-methionine + choline chloridemethionine + choline chlorideracemetionina + cloreto de colina
02

Targets

MAT (Monoamine transporters)Choline-utilizing phosphatidylcholine synthesis enzymes

Beyond the preview

Go deeper on racemethionine + choline chloride.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on racemethionine + choline chloride.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call